Abstract:Vascular endothelial growth factor (VEGF) has protective effects on many neurological diseases. However, whether VEGF acts on brain edema following intracerebral hemorrhage (ICH) is largely unknown. Our previous study has shown aquaporin-4 (AQP4) plays an important role in brain edema elimination following ICH. Meanwhile, there is close relationship between VEGF and AQP4. In this study, we aimed to test effects of VEGF on brain edema following ICH and examine whether they were AQP4 dependent. Recombinant human VEGF165 (rhVEGF165) was injected intracerebroventricularly 1 d after ICH induced by microinjecting autologous whole blood into striatum. We detected perihemotomal AQP4 protein expression, then examined the effects of rhVEGF165 on perihemotomal brain edema at 1 d, 3 d, and 7 d after injection in wild type (AQP4(+/+)) and AQP4 knock-out (AQP4(-/-)) mice. Furthermore, we assessed the possible signal transduction pathways activated by VEGF to regulate AQP4 expression via astrocyte cultures. We found perihemotomal AQP4 protein expression was highly increased by rhVEGF165. RhVEGF165 alleviated perihemotomal brain edema in AQP4(+/+) mice at each time point, but had no effect on AQP4(-/-) mice. Perihemotomal EB extravasation was increased by rhVEGF165 in AQP4(-/-) mice, but not AQP4(+/+) mice. RhVEGF165 reduced neurological deficits and increased Nissl's staining cells surrounding hemotoma in both types of mice and these effects were related to AQP4. RhVEGF165 up-regulated phospharylation of C-Jun amino-terminal kinase (p-JNK) and extracellular signal-regulated kinase (p-ERK) and AQP4 protein in cultured astrocytes. The latter was inhibited by JNK and ERK inhibitors. In conclusion, VEGF reduces neurological deficits, brain edema, and neuronal death surrounding hemotoma but has no influence on BBB permeability. These effects are closely related to AQP4 up-regulation, possibly through activating JNK and ERK pathways. The current study may present new insights to treatment of brain edema following ICH.

Aquaporin-4 and Cerebrovascular Diseases

Aquaporin-4 and Traumatic Brain Edema.

Aquaporin 4 and Cerebrovascular Disease

Research progress in role of apuaporin4 in treatnment of brain edema

Aquaporin-4: A Potential Therapeutic Target for Cerebral Edema

Targeting Water in Brain: Role of Aquaporin-4 in Ischemic Brain Edema.

Aquaporin 4 and Cerebral Edema

The central role of aquaporins in the pathophysiology of ischemic stroke

Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke

Recent advance of aquaporin-4 in neurodegenerative diseases

[AQP4 Regulation for Cerebral Edema].

The aquaporin-4 water channel as a potential drug target in neurological disorders

Research about Relationship between AQP4 and Brain Edema Following Intracerebral Hemorrhage

Targeting Aquaporin-4 Subcellular Localization to Treat Central Nervous System Edema

Effects of Aquaporin-4 on Edema Formation Following Intracerebral Hemorrhage

Aquaporin-4 and Cognitive Disorders

Aquaporin proteins: A promising frontier for therapeutic intervention in cerebral ischemic injury

Aquaporin-4 Water Channel in the Brain and Its Implication for Health and Disease

Relationship between aquaporin-4 expression and blood-brain barrier damage after acute experimental intracerebral hemorrhage

Regulation of AQP4 in the Central Nervous System

Aquaporins in Cardiovascular System